XML 27 R14.htm IDEA: XBRL DOCUMENT v3.24.1
SHARE BASED COMPENSATION
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Share-Based Payment Arrangement [Text Block]

7 - SHARE BASED COMPENSATION

 

Our 2018 Stock Incentive Plan (the “Plan”) authorizes the issuance of up to 1,000,000 shares pursuant to options or awards granted under the Plan. Under the Plan, incentive stock and nonstatutory options were granted at prices equal to at least the fair market value of our Class A common stock at the date of grant. Outstanding options vest in three (3) equal annual installments beginning one (1) year from the date of grant and are subject to termination provisions as defined in the Plan. There was no options granted in 2023, and the fair values of options in 2022 were estimated using the Black-Scholes option-pricing model at their respective grant date using the following assumptions:

 

 

   

Year Ended December 31,

 
   

2022

 

Weighted-average grant date fair value per share

 

$0.11 - $0.38

 

Risk-free interest rate

    2.8 %

Dividend yield

    5.3 %

Expected term (in years)

    10  

Volatility

    16 %

 

Stock option activity during the periods indicated is as follows:

 

   

Number

of Shares

   

Weighted Average

Exercise Price

   

Weighted Average

Years Remaining

Contractual Term

   

Aggregate

Intrinsic Value

 
                                 

Outstanding at December 31, 2021

    294,100     $ 2.45       5.0     $ 492,000  

Grants

    60,500       3.54       7.5       -  

Exercised

    (120,000 )     1.74       -       -  

Forfeited

    (10,000 )     3.40       -       -  

Outstanding at December 31, 2022

    224,600     $ 2.45       5.0     $ 492,000  

Exercised

    (25,000 )     2.14       -       -  

Forfeited

    (3,000 )     0.96       -       -  

Outstanding at December 31, 2023

    196,600     $ 3.25       5.5     $ 112,000  

Exercisable at December 31, 2023

    140,900     $ 3.01       5.1     $ 109,100  

 

At December 31, 2023, the range of individual weighted average exercise prices was $2.42 to $4.44 and the unamortized compensation expense was approximately $11,000.